Intech Investment Management LLC Has $1.68 Million Stake in Ingevity Corporation $NGVT

Intech Investment Management LLC grew its stake in Ingevity Corporation (NYSE:NGVT) by 106.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 28,389 shares of the company’s stock after purchasing an additional 14,645 shares during the period. Intech Investment Management LLC owned about 0.08% of Ingevity worth $1,680,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Wealth Enhancement Advisory Services LLC boosted its position in Ingevity by 3.1% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 7,823 shares of the company’s stock valued at $418,000 after buying an additional 238 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Ingevity by 15.7% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,870 shares of the company’s stock valued at $103,000 after acquiring an additional 254 shares during the last quarter. Advisory Services Network LLC lifted its stake in shares of Ingevity by 4.4% in the 3rd quarter. Advisory Services Network LLC now owns 6,947 shares of the company’s stock valued at $383,000 after acquiring an additional 293 shares during the last quarter. Amundi boosted its holdings in shares of Ingevity by 4.8% during the 3rd quarter. Amundi now owns 6,626 shares of the company’s stock valued at $364,000 after acquiring an additional 302 shares in the last quarter. Finally, Isthmus Partners LLC boosted its holdings in shares of Ingevity by 0.5% during the 4th quarter. Isthmus Partners LLC now owns 72,245 shares of the company’s stock valued at $4,275,000 after acquiring an additional 375 shares in the last quarter. 91.59% of the stock is owned by institutional investors.

Insider Activity

In other news, SVP Terrance M. Dyer sold 496 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the transaction, the senior vice president owned 7,202 shares in the company, valued at approximately $493,264.98. The trade was a 6.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.88% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a research report on Tuesday, April 21st. Jefferies Financial Group reaffirmed a “buy” rating and issued a $82.00 price objective on shares of Ingevity in a research note on Thursday, February 26th. Wall Street Zen upgraded shares of Ingevity from a “hold” rating to a “strong-buy” rating in a research report on Saturday, May 9th. BMO Capital Markets reissued an “outperform” rating and set a $83.00 target price on shares of Ingevity in a report on Monday, March 2nd. Finally, Wells Fargo & Company upped their price target on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $80.00.

Ingevity Trading Down 1.3%

Shares of NGVT stock opened at $66.10 on Friday. Ingevity Corporation has a 1-year low of $39.74 and a 1-year high of $79.29. The company has a current ratio of 1.42, a quick ratio of 0.92 and a debt-to-equity ratio of 27.83. The stock has a market cap of $2.30 billion, a price-to-earnings ratio of -18.62 and a beta of 1.18. The stock has a 50-day moving average of $71.67 and a 200-day moving average of $66.34.

Ingevity (NYSE:NGVT) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The company had revenue of $258.00 million for the quarter, compared to analyst estimates of $254.73 million. During the same period in the previous year, the firm earned $1.01 earnings per share. The firm’s quarterly revenue was up 4.1% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, equities research analysts forecast that Ingevity Corporation will post 5.05 earnings per share for the current year.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.